KR830003415A - 15-설폰 아미도 프로스타글란딘 유도체 - Google Patents

15-설폰 아미도 프로스타글란딘 유도체 Download PDF

Info

Publication number
KR830003415A
KR830003415A KR1019800003623A KR800003623A KR830003415A KR 830003415 A KR830003415 A KR 830003415A KR 1019800003623 A KR1019800003623 A KR 1019800003623A KR 800003623 A KR800003623 A KR 800003623A KR 830003415 A KR830003415 A KR 830003415A
Authority
KR
South Korea
Prior art keywords
prostaglandin derivative
carbon atoms
sulfon amido
sulfon
amido
Prior art date
Application number
KR1019800003623A
Other languages
English (en)
Other versions
KR840000964B1 (ko
Inventor
켄 샤프 토마스
프레드릭 에글러 제임스
Original Assignee
윌리암 지. 맥크리이리
화이자 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 윌리암 지. 맥크리이리, 화이자 인코포레이티드 filed Critical 윌리암 지. 맥크리이리
Publication of KR830003415A publication Critical patent/KR830003415A/ko
Application granted granted Critical
Publication of KR840000964B1 publication Critical patent/KR840000964B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

내용 없음

Description

15-설폰 아미도 프로스타글란딘 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 탄소수 2내지 4의 희알카노산 및 물과 다음 구조식 II의 중간체를 반응시키고, THPO그룹을 가수분해 하는 것을 특징으로 하여 다음 구조식 I의 15-설폰아미도 프로스타글란딘 유도체를 제조하는 방법.
    상기식에서
    Q는-CO2H,-CO2R, 테트라졸-5-릴, -CONHSO2R 또는 -CONHCOR이며;
    A는 에틸렌 또는 시스-비닐렌이며;
    X는 H, F, Cl, Br, OCH3, CF3또는 CH3이며,
    R은 탄소수 1내지 4의 알킬 또는 페닐이며, THOP는 테트라하이드로피라닐옥시이다.
    ※참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019800003623A 1979-09-17 1980-09-16 15-설폰아미도프로스타글란딘 유도체의 제조방법 KR840000964B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US076.520 1979-09-17
US06/076,520 US4232173A (en) 1979-09-17 1979-09-17 15-Sulfonamidoprostaglandin derivatives
US076520 1993-06-14

Publications (2)

Publication Number Publication Date
KR830003415A true KR830003415A (ko) 1983-06-20
KR840000964B1 KR840000964B1 (ko) 1984-07-02

Family

ID=22132532

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019800003623A KR840000964B1 (ko) 1979-09-17 1980-09-16 15-설폰아미도프로스타글란딘 유도체의 제조방법

Country Status (18)

Country Link
US (1) US4232173A (ko)
EP (1) EP0025687B1 (ko)
JP (1) JPS5951938B2 (ko)
KR (1) KR840000964B1 (ko)
AR (1) AR225776A1 (ko)
AT (1) ATE1858T1 (ko)
AU (1) AU518068B2 (ko)
CA (1) CA1153368A (ko)
DE (1) DE3061160D1 (ko)
DK (1) DK392580A (ko)
ES (1) ES8106489A1 (ko)
FI (1) FI68615C (ko)
GR (1) GR70288B (ko)
IE (1) IE50266B1 (ko)
IL (1) IL61038A (ko)
PH (1) PH15098A (ko)
PT (1) PT71807B (ko)
YU (1) YU236180A (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61126069A (ja) * 1984-11-21 1986-06-13 Res Dev Corp Of Japan プロスタグランジン誘導体
JPS63207015A (ja) * 1987-02-23 1988-08-26 株式会社日立製作所 遮断器装置
JPS6429564A (en) * 1987-07-25 1989-01-31 Oyo Kikaku Kk Common joist mechanism
US5387608A (en) * 1993-08-17 1995-02-07 Allergan, Inc. Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl sulfonamidomethyl and derivatives thereof as therapeutic agents
US5607415A (en) * 1994-08-18 1997-03-04 Kimberly-Clark Corporation Flexible absorbent article

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3835179A (en) * 1972-07-24 1974-09-10 American Cyanamid Co Novel 15-substituted prostanoic acids and esters
US4033996A (en) * 1973-04-25 1977-07-05 Merck & Co., Inc. 8-Aza-9-oxo(and dioxo)-thia-11,12-secoprostaglandins
GB1507211A (en) * 1975-02-14 1978-04-12 Ono Pharmaceutical Co Prostaglandin analogues

Also Published As

Publication number Publication date
EP0025687B1 (en) 1982-11-24
PT71807B (en) 1981-07-02
IE801927L (en) 1981-03-17
KR840000964B1 (ko) 1984-07-02
FI68615B (fi) 1985-06-28
IE50266B1 (en) 1986-03-19
PH15098A (en) 1982-08-10
JPS5651448A (en) 1981-05-09
IL61038A (en) 1983-12-30
DE3061160D1 (en) 1982-12-30
AU6243680A (en) 1981-03-26
GR70288B (ko) 1982-09-03
PT71807A (en) 1980-10-01
FI802904A (fi) 1981-03-18
ATE1858T1 (de) 1982-12-15
EP0025687A1 (en) 1981-03-25
US4232173A (en) 1980-11-04
DK392580A (da) 1981-03-18
IL61038A0 (en) 1980-11-30
CA1153368A (en) 1983-09-06
JPS5951938B2 (ja) 1984-12-17
FI68615C (fi) 1985-10-10
ES495101A0 (es) 1981-08-16
AR225776A1 (es) 1982-04-30
ES8106489A1 (es) 1981-08-16
YU236180A (en) 1983-01-21
AU518068B2 (en) 1981-09-10

Similar Documents

Publication Publication Date Title
KR850000406A (ko) 4-클로로-2-페닐이미다졸-5-아세트산유도체의 제조방법
KR830004309A (ko) β-락타마제 억제제로써의 6β-하이드록시 알킬 페니실란산 유도체
KR840006203A (ko) N-포르밀 및 n-하이드록시메틸-3-펜옥시-1-아제티딘카복스아미드의 제조방법
KR830005092A (ko) 시클로프로판 카르복실산의 새로운 유도체
KR840005715A (ko) 3-페녹시-1-아제티딘 카아복사마이드의 제조방법
KR830003417A (ko) 메틸렌-사이클로아민의 제조방법
KR830007626A (ko) 2-(1,4-벤조디옥산-2-일알킬) 이미다졸류의 제조방법
KR830003415A (ko) 15-설폰 아미도 프로스타글란딘 유도체
KR870007106A (ko) 테트라클로로-2-시아노벤조산의 알킬에스테르의 제조방법
KR850001724A (ko) 4-페닐-4-옥소-부텐-2-오인산유도체의 제조방법
KR860004010A (ko) N-[6-메톡시-5-(퍼플루오로알킬)-1-나프토일]-n-메틸글리신 및 이의 티오프토일 동족체의 제조방법
KR840005070A (ko) 아미노알카디엔 유도체의 제조방법
KR830007580A (ko) 신규 피리미딘 유도체의 제조방법
KR840005713A (ko) [3.2.0]비시클로헵탄온 옥심 에테르류의 제조방법
KR830005122A (ko) 1-아릴옥시-3-알킬아미노-2-프로판올류의 제조방법
KR830001890A (ko) 카바졸 유도체의 제조방법
SE7907188L (sv) Sett att framstella hydroximetyl-4(5)-legre alkyl-5(4)-imidazoler och deras syraadditionssalter
KR830006285A (ko) 벤조퀴놀리진의 제조방법
KR840004720A (ko) 살충제 조성물 및 이의 제조방법
KR890014441A (ko) 케토-디에스테르류 및 이들의 제법
KR830001184A (ko) 페닐 알카노일산 유도체의 제조방법
KR850001744A (ko) 4-r'-5-q-1,6-나프티리딘-2(1h)-온류의 제법
KR830003402A (ko) 할로 아세트 아미드의 제조방법
KR830001183A (ko) 페닐알카노일산 유도체의 제조방법
KR830001265A (ko) 새로운 티아디아졸 화합물류와 그 제조방법